Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research

Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncology. Although it is considered a standard for resected stage II-IIIA patients according to the available guidelines, many questions are still open. Among them, it should be acknowledged that the treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Bonomi, Maria, Pilotto, Sara, Milella, Michele, Massari, Francesco, Cingarlini, Sara, Brunelli, Matteo, Chilosi, Marco, Tortora, Giampaolo, Bria, Emilio
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284429/
https://ncbi.nlm.nih.gov/pubmed/22206620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-115
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items